Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer-Reference-Cited by-同舟云学术

Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer

Published:2006-07-20 Issue:10 Volume:119 Page:2322-2329
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Hu Shuiying,Liu Dingxie,Tufano Ralph P.,Carson Kathryn A.,Rosenbaum Eli,Cohen Yoram,Holt Elizabeth H.,Kiseljak-Vassiliades Katja,Rhoden Kerry J.,Tolaney Sara,Condouris Stephen,Tallini Giovanni,Westra William H.,Umbricht Christopher B.,Zeiger Martha A.,Califano Joseph A.,Vasko Vasily,Xing Mingzhao

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference36 articles.

1. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995;Hundahl;Cancer,1998

2. Thyroid cancer in Wales 1985-1996: a cancer registry-based study;Paterson;Clin Oncol,1999

3. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989;Hay;Surgery,1993

4. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer;Mazzaferri;Am J Med,1994

5. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991;Gilliland;Cancer,1997

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of mitochondria and potential of mitochondria-targeted therapy in BRAF mutant cancer: A review;Critical Reviews in Oncology/Hematology;2024-11

2. Tissue Inhibitor of Metalloproteinase 3: Unravelling Its Biological Function and Significance in Oncology;International Journal of Molecular Sciences;2024-03-10

3. Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation;Oncotarget;2024-01-24

4. Role of SLC5A8 as a Tumor Suppressor in Cervical Cancer;Frontiers in Bioscience-Landmark;2024-01-17

5. Advances and challenges in thyroid cancer: The interplay of genetic modulators, targeted therapies, and AI-driven approaches;Life Sciences;2023-11